Contact Us
For Product Pricing, Customization, Or Other Inquiries:
Contact Supplier
Call Us
Factory Supply Imatinib
Factory Supply Imatinib
Name |
Imatinib |
Synonyms |
4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide |
Brand |
IdoBio |
Molecular Formula |
C29H31N7O |
Molecular Weight |
493.60 |
CAS Registry Number |
152459-95-5 |
Test Items |
Specification |
Results |
Description |
Light yellow to white crystalline powder |
Comply |
Melting point |
166-170°C |
167.3-168.1°C |
Identification |
Positive reaction |
Positive reaction |
Related substances |
≤1.0% |
0.16% |
Loss on drying |
≤0.5% |
0.06% |
Residue on ignition |
≤0.1% |
0.02% |
Chloride |
≤0.014% |
<0.014 |
Heavy Metals |
≤20ppm |
<20ppm |
Clarity of solution |
Conform to standard |
Complies |
Microbial Limit |
≤20ppm |
<20ppm |
Assay |
≥99.0% |
99.12% |
Imatinib base is the intermediate of Imatinib mesylate, Imatinib, sold under the brand names Gleevec among others, is a chemotherapy medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that is Philadelphia chromosome-positive (Ph+) and certain types of gastrointestinal stromal tumors (GIST), systemic mastocytosis, and myelodysplastic syndrome.